XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference
CALGARY, Alberta, Jan. 10, 2022 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive […]